GUANZE MEDICAL Announces New Leadership Appointments Including Chairman and CEO

Stock News06-30

GUANZE MEDICAL (ASX: 02427) has announced a series of changes to its board and executive leadership team, effective July 1, 2026. Mr. Zhenyu Guo has resigned from his position as an executive director of the company. Additionally, Ms. Cathy Meng has stepped down from her roles as a non-executive director and a member of the board's nomination committee.

Concurrently, the company has appointed Ms. Jiang Ceman as an executive director, the chairperson of the nomination committee, and a member of the board's remuneration committee. Ms. Qin Jingying has been appointed as an executive director. Further leadership changes see Ms. Jiang Ceman appointed as the company's chief executive officer and chairperson of the board, as well as an authorized representative, effective from the same date.

Mr. Meng Xianzhen will no longer serve as the chief executive officer, board chairman, or authorized representative. However, he will continue his tenure with the company as an executive director.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173064185?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 23:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173064185","market":"us","top_or_hot":-1,"title":"GUANZE MEDICAL Announces New Leadership Appointments Including Chairman and CEO","media":"Stock News","content":"<p><b>GUANZE MEDICAL</b> (<b>ASX: 02427</b>) has announced a series of changes to its board and executive leadership team, effective July 1, 2026. Mr. Zhenyu Guo has resigned from his position as an executive director of the company. Additionally, Ms. Cathy Meng has stepped down from her roles as a non-executive director and a member of the board's nomination committee.<br><br>Concurrently, the company has appointed Ms. Jiang Ceman as an executive director, the chairperson of the nomination committee, and a member of the board's remuneration committee. Ms. Qin Jingying has been appointed as an executive director. Further leadership changes see Ms. Jiang Ceman appointed as the company's chief executive officer and chairperson of the board, as well as an authorized representative, effective from the same date.<br><br>Mr. Meng Xianzhen will no longer serve as the chief executive officer, board chairman, or authorized representative. However, he will continue his tenure with the company as an executive director.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GUANZE MEDICAL Announces New Leadership Appointments Including Chairman and CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGUANZE MEDICAL Announces New Leadership Appointments Including Chairman and CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-30 23:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>GUANZE MEDICAL</b> (<b>ASX: 02427</b>) has announced a series of changes to its board and executive leadership team, effective July 1, 2026. Mr. Zhenyu Guo has resigned from his position as an executive director of the company. Additionally, Ms. Cathy Meng has stepped down from her roles as a non-executive director and a member of the board's nomination committee.<br><br>Concurrently, the company has appointed Ms. Jiang Ceman as an executive director, the chairperson of the nomination committee, and a member of the board's remuneration committee. Ms. Qin Jingying has been appointed as an executive director. Further leadership changes see Ms. Jiang Ceman appointed as the company's chief executive officer and chairperson of the board, as well as an authorized representative, effective from the same date.<br><br>Mr. Meng Xianzhen will no longer serve as the chief executive officer, board chairman, or authorized representative. However, he will continue his tenure with the company as an executive director.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1173064185","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173064185","pubTimestamp":1782832345,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"GUANZE MEDICAL (ASX: 02427) has announced a series of changes to its board and executive leadership team, effective July 1, 2026. Mr. Zhenyu Guo has resigned from his position as an executive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02427":"GUANZE MEDICAL","BK1197":"保健护理产品经销商"},"translate_title":"冠泽医疗宣布包括董事长和首席执行官在内的新领导层任命","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"GUANZE MEDICAL (ASX: 02427) has announced a series of changes to its board and executive leadership team, effective July 1, 2026. Mr. Zhenyu Guo has resigned from his position as an executive director of the company. Additionally, Ms. Cathy Meng has stepped down from her roles as a non-executive director and a member of the board's nomination committee.Concurrently, the company has appointed Ms. Jiang Ceman as an executive director, the chairperson of the nomination committee, and a member of the board's remuneration committee. Ms. Qin Jingying has been appointed as an executive director. Further leadership changes see Ms. Jiang Ceman appointed as the company's chief executive officer and chairperson of the board, as well as an authorized representative, effective from the same date.Mr. Meng Xianzhen will no longer serve as the chief executive officer, board chairman, or authorized representative. However, he will continue his tenure with the company as an executive director.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173064185","isCrawlerRequest":true}